Tofacitinib: a successful treatment option for SAPHO syndrome

dc.authorid, Sezgi/0000-0002-8572-8249
dc.contributor.authorSarikaya Solak, Sezgi
dc.contributor.authorYelgen Ilyas, Hande
dc.date.accessioned2024-06-12T11:19:05Z
dc.date.available2024-06-12T11:19:05Z
dc.date.issued2024
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1111/ijd.17075
dc.identifier.endpage674en_US
dc.identifier.issn0011-9059
dc.identifier.issn1365-4632
dc.identifier.issue5en_US
dc.identifier.pmid38357788en_US
dc.identifier.scopus2-s2.0-85185133595en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage671en_US
dc.identifier.urihttps://doi.org/10.1111/ijd.17075
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25075
dc.identifier.volume63en_US
dc.identifier.wosWOS:001162654500001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal Of Dermatologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHyperostosisen_US
dc.subjectPustulosisen_US
dc.subjectSynovitisen_US
dc.subjectAcneen_US
dc.titleTofacitinib: a successful treatment option for SAPHO syndromeen_US
dc.typeLetteren_US

Dosyalar